Sign in
4

Changes in Ownership

Tyra Biosciences, Inc. Filed Acc 0001209191-23-021564

Chief Operating Officer sold 13,581 shares at an average $16.03 ($217,763)

  • Chief Operating Officer acquired 13,581 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Bensen Daniel Chief Operating Officer 2023-03-27 Option exercise +8,048 $0.61 $4,909 536,029 D
Bensen Daniel Chief Operating Officer 2023-03-27 Sale −8,048 $16.00 $128,768 527,981 D
Bensen Daniel Chief Operating Officer 2023-03-28 Option exercise +3,346 $0.61 $2,041 531,327 D
Bensen Daniel Chief Operating Officer 2023-03-28 Sale −3,346 $16.00 $53,536 527,981 D
Bensen Daniel Chief Operating Officer 2023-03-29 Option exercise +2,187 $0.61 $1,334 530,168 D
Bensen Daniel Chief Operating Officer 2023-03-29 Sale −2,187 $16.21 $35,459 527,981 D
Derivatives
Bensen Daniel Chief Operating Officer 2023-03-27 Option exercise · Stock Option (Right to Buy) −8,048 239,354 D
Bensen Daniel Chief Operating Officer 2023-03-28 Option exercise · Stock Option (Right to Buy) −3,346 236,008 D
Bensen Daniel Chief Operating Officer 2023-03-29 Option exercise · Stock Option (Right to Buy) −2,187 233,821 D
Open-market sales · 13,581 sh · avg $16.03 · $217,763
Loading xslF345X04/doc4.xml…